Eric Venker Insider Trades & Stock Holdings

President & Immunovant CEO · Roivant Sciences Ltd. · Latest filing Jun 24, 2026

Eric Venker, President & Immunovant CEO at Roivant Sciences Ltd. has 2 Form 4 trades on file since Jun 24, 2026. Latest filing: disposed of 200K shares of $ROIV on Jun 24, 2026.

Trades on file: 2
Open-market bought: $0
Open-market sold: $0
Net open-market: $0
Latest filing: Jun 24, 2026

All insider trades by Eric Venker

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 24, 2026	$ROIV	Sell (Option exercise)	200K	$0	—			+3.0%	+2.9%		President & Immunovant CEO		Read
Jun 24, 2026	$ROIV	Buy (Option exercise)	200K	$3.85	$770K			+3.0%	+2.9%		President & Immunovant CEO		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Eric Venker traded

$ROIV

Frequently asked questions

What was Eric Venker's latest insider trade?

disposed of 200K shares of $ROIV on Jun 24, 2026.

All insiders Insider cluster buys Top insider purchases Latest insider trade news

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text